Clinical Outcomes in Breast Cancer: Innovations and Ideas Commentary on "Expression of CDK13 was Associated with Clinical Outcomes and Expression of HIF-1 and Beclin1 in Breast Cancer Patients"

J Invest Surg. 2022 Feb;35(2):448-449. doi: 10.1080/08941939.2020.1861137. Epub 2020 Dec 28.

Authors

Giuseppe Diluiso¹, Roberto Cuomo¹, Francesco Volanti¹, Giuseppe Nisi¹, Margherita Aglianò², Francesco Ruben Giardino¹, Luigi Losco³, Luca Grimaldi¹

Affiliations

¹ Department of Medicine, Surgery and Neuroscience, Unit of Plastic Surgery, University of Siena, Siena, Italy.
² Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
³ Department of Translational Research and New Technologies in Medicine and Surgery, Plastic Surgery Unit, University of Pisa, Pisa, Italy.

PMID: 33371758
DOI: 10.1080/08941939.2020.1861137

No abstract available

Publication types

Comment

MeSH terms

Autophagy
Beclin-1 / genetics
Breast Neoplasms*
CDC2 Protein Kinase
Cell Line, Tumor
Female
Humans

Substances

Beclin-1
CDC2 Protein Kinase
CDK13 protein, human